Keep On Keep Up Bladder Health: Co-creating and Testing a Self-management Technological Solution for Ageing Well
KOKU Bladder
On Any Page, Select Quit to Stop Entering Data. Data Entered on Previous Pages Will be Retained: To Complete Data Entry Later, Open the Record From the Home Page
1 other identifier
interventional
120
3 countries
4
Brief Summary
KOKU Bladder aims to develop and test an evidence based digital health program with behavior change techniques to improve bladder health of adults aged 50 and over. A novel module embedded in the approved app "Keep-on-Keep-up" (KOKU) will be co-created with end-users, researchers, health professionals, and stakeholders through a participatory and appreciative action and reflection methodology. After a comprehensive literature review and consultation with 4-6 experts, 6 focus groups will be undertaken in Kaunas(Lithuanian), Catalonia (Spain) and Manchester (UK) to co-create the contents of the module. Data will be analyzed using thematic analysis. Gamification and the Honeycomb model for user experience will be followed to achieve an appropriate technological solution that will be tested through a randomized controlled trial with at least 120 individuals. A mixed methods approach (quantitative/qualitative analysis) will be used to assess the feasibility and acceptability of the program. Open data and science, gender and ethical aspects, as well as a risk management plan are considered. A plan for communication, dissemination, exploitation of results will be considered. KOKU Bladder will be highly scalable and will have wide reach and impact. This proposal is in line with EU policy initiatives on Active and Healthy Ageing (bladder health and continence will be promoted), targeting aspects such as eHealth, Innovation and Digital Care Transformation, by supporting users to demand more responsive and integrated care programs for chronic conditions and enhancing self-management strategies, independence and health intelligence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2025
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 1, 2024
CompletedFirst Posted
Study publicly available on registry
September 4, 2024
CompletedStudy Start
First participant enrolled
March 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2028
March 30, 2025
March 1, 2025
2.4 years
September 1, 2024
March 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To co-create, develop and test an evidence based digital health program with behavior change techniques to decrease UI of community-dwelling adults aged 50 and over
The primary aim of KOKU Bladder is to co-create and test an eHealth program to address bladder health (specifically urinary incontinence) in community-dwelling adults aged 50 and over
3 years
Secondary Outcomes (5)
To evaluate the life-impact related to UI (Incontinence Impact Questionnaire-7) of community-dwelling adults aged 50 and over.
3 years
To evaluate the lower urinary tract symptoms (International Prostate Symptom Score) of community-dwelling adults aged 50 and over.
3 years
To evaluate the Patient Global Impression of Improvement; SB (visual analogue scale, a 7-day recall period) of community-dwelling adults aged 50 and over
3 years
To evaluate the satisfaction with treatment of community-dwelling adults aged 50 and over.
3 years
To modify the severity of UI (International Consultation on Incontinence Questionnaire-UI short form) of community-dwelling adults aged 50 and over
3 years
Study Arms (2)
control group
ACTIVE COMPARATORThe control group which will receive recommendations for self- managing urinary symptoms. There will be at least 60 participants (men and women mixed) distributed in 3 countries. It is anticipated that the multicomponent intervention will last 12 weeks. After the intervention we will collect the results with a mixed (qualitative and quantitative) approach.
intervention group
EXPERIMENTALThe intervention group, which will receive the treatment with KOKU Bladder. There will be at least 60 participants (men and women mixed) distributed in 3 countries. It is anticipated that the multicomponent intervention will last 12 weeks. After the intervention we will collect the results with a mixed (qualitative and quantitative) approach.
Interventions
In this intervention the participants will receive treatment with the KOKU app ( based digital health program with behavior change techniques to improve bladder health ) for 12 weeks. After the intervention we will collect the results with a mixed (qualitative and quantitative) approach. Qualitative information will be recorded and analysed through thematic analysis, and quantitative data will be collected with tests and questionnaires.
In this intervention the participants will receive recommendations for self- managing urinary symptoms, which they must follow for 12 weeks. After the intervention we will collect the results with a mixed (qualitative and quantitative) approach. Qualitative information will be recorded and analysed through thematic analysis, and quantitative data will be collected with tests and questionnaires.
Eligibility Criteria
You may qualify if:
- Age ≥50 (range used in the literature covering the late-life process, including prostate issues and the perimenopause period)
- Self-reported UI (at least 1 leakage/month)
- Ability to read and understand the national languages
- Have a mobile phone/tablet
- Sign informed consent.
You may not qualify if:
- Red-flag symptoms (e.g., bleeding)
- Unstable health conditions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Vic - Central University of Catalonialead
- Hospital Universitari Santa Maria de Lleida (GSS)collaborator
- Institut de Recerca i Innovació en Ciències de la Vida i de la Salut a la Catalunya Central (IRIS)collaborator
- University of Manchestercollaborator
- Research Council of Lithuaniacollaborator
- Lithuanian Sports Universitycollaborator
- Agencia Gestió Ajuts Universitaris i Recercacollaborator
- Consorci Hospitalari de Vic (CHV)collaborator
Study Sites (4)
Lithuanian Sports University
Kaunas, Lithuania
Hospital Santa Maria
Lleida, Spain
Hospital Consortium of Vic
Vic, Spain
University of Manchester
Manchester, United Kingdom
Related Publications (1)
Jerez-Roig J, Aguila-Gimeno O, Brazaitis M, Solianik R, Karkauskiene E, Jarutiene L, Fuente-Vidal A, Borralleras-Fumana E, Gasteiger N, Stanmore E. Co-creating and testing a self-management digital solution for bladder health and urinary continence among people aged 50 and over: protocol for the international KOKU Bladder project. BMJ Open. 2025 Sep 11;15(9):e100487. doi: 10.1136/bmjopen-2025-100487.
PMID: 40940057DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jerez-Roig, PhD
University of Vic-Central University of Catalonia; Lithuanian Sports University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Usually, in physiotherapist studies it is very difficult to do blinding, because the patients can do some physical activity or exercise. In this trial, participants blinding will not be possible because the patients know what treatment they do, they should do the different exercises with app or with a HB information. Also, it is necessary to do face-to-face assessment for the physiotherapist.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Head of research group on Methodology, Methods, Models and Outcomes of Health and Social Science (M3O)
Study Record Dates
First Submitted
September 1, 2024
First Posted
September 4, 2024
Study Start
March 24, 2025
Primary Completion (Estimated)
August 31, 2027
Study Completion (Estimated)
October 1, 2028
Last Updated
March 30, 2025
Record last verified: 2025-03